Bluebird Bio vs Lexeo Therapeutics
Bluebird Bio vs Lexeo Therapeutics, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Bluebird Bio is on 51/100 and Lexeo Therapeutics on 61/100.
Where each one leads
Bluebird Bio
- agent readiness: 46/100 against 40/100
- domain rating: 56/100 against 41/100
- headcount: 137 against 91
- funding raised: $1.0B against $495M
- LinkedIn following: 141,691 against 16,654
Lexeo Therapeutics
- our overall score: 61/100 against 51/100
At a glance
| Measure | Bluebird Bio | Lexeo Therapeutics |
|---|---|---|
| What it is | Gene therapy company developing transformative treatments for severe genetic diseases. | Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 1992 | 2020 |
| Headquarters | Somerville, United States | New York City, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Bluebird Bio | Lexeo Therapeutics |
|---|---|---|
| Employees | 137 | 91 |
| Open roles | 16 | Not published |
| Total funding | $1.0B | $495M |
| Latest round | Series D | Public Offering |
| LinkedIn followers | 141,691 | 16,654 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Bluebird Bio | Lexeo Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 51/100 | 61/100 |
| Traction | 60/100 | 60/100 |
| Team | 30/100 | 70/100 |
| Community | Not published | 8/100 |
| Search visibility | 25/100 | 28/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (46/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 56/100 | 41/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Bluebird Bio | Lexeo Therapeutics |
|---|---|---|
| Hosting | AWS | Self Managed |
| CMS | Not detected | WordPress |
| Frameworks | Bootstrap | Jquery |
| Analytics | Google Tag Manager | Google Tag Manager |
Bluebird Bio vs Lexeo Therapeutics: common questions
Which is better, Bluebird Bio or Lexeo Therapeutics?
On our 0-100 score Lexeo Therapeutics rates higher (61/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do Bluebird Bio and Lexeo Therapeutics compare on the numbers?
Bluebird Bio leads on agent readiness (46/100 against 40/100), domain rating (56/100 against 41/100), headcount (137 against 91), funding raised ($1.0B against $495M), LinkedIn following (141,691 against 16,654). Lexeo Therapeutics leads on our overall score (61/100 against 51/100).
Read the full Bluebird Bio review and pricing or the Lexeo Therapeutics review and pricing. You can also browse other Bluebird Bio alternatives we track.